Compare FBK & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | FBK | HTFL |
|---|---|---|
| Founded | 1906 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.2B |
| IPO Year | 2016 | 2025 |
| Metric | FBK | HTFL |
|---|---|---|
| Price | $53.96 | $51.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $64.50 | $38.20 |
| AVG Volume (30 Days) | 340.6K | ★ 1.7M |
| Earning Date | 04-13-2026 | 05-14-2026 |
| Dividend Yield | ★ 1.56% | N/A |
| EPS Growth | N/A | ★ 82.37 |
| EPS | ★ 2.24 | N/A |
| Revenue | N/A | ★ $176,034,000.00 |
| Revenue This Year | $41.72 | $27.66 |
| Revenue Next Year | $7.21 | $23.55 |
| P/E Ratio | $23.88 | ★ N/A |
| Revenue Growth | N/A | ★ 39.92 |
| 52 Week Low | $49.74 | $20.13 |
| 52 Week High | $62.66 | $51.78 |
| Indicator | FBK | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 35.32 | 68.21 |
| Support Level | $52.85 | $46.27 |
| Resistance Level | $55.88 | $51.48 |
| Average True Range (ATR) | 1.23 | 2.55 |
| MACD | -0.21 | -0.57 |
| Stochastic Oscillator | 19.43 | 83.24 |
FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates majority of revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.